Novocure's device shown to slow cancer progression in the brain in trial
Go back to Novocure's device shown to slow cancer progression in the brain in trial| (NASDAQ: NVCR) | Delayed: 14.28 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $14.28 | 52 Week High | $28.95 | |||
| Open | $14.28 | 52 Week Low | $5.95 | |||
| Day High | $14.28 | P/E | N/A | |||
| Day Low | $14.28 | EPS | $0.00 | |||
| Volume | 1,244 | |||||

